Literature DB >> 8196301

[Autologous transplantation of nasal mucosa after severe chemical and thermal eye burns].

R Kuckelkorn1, M Wenzel, J Lamprecht, B Böcking, M Reim.   

Abstract

BACKGROUND: Extensive conjunctival scarring is common after severe chemical and thermal eye burns. There is often not enough healthy conjunctiva from the other eye available to correct the symblepharons, therefore other autologous tissues have to be transplanted. PATIENTS AND METHODS: From February 1992 until March 1993 13 patients were treated with free nasal mucosal grafts from the inferior turbinates for reconstruction of the fornices. The newly created deep fornices were secured by a silicone band. In 3 patients an Illig plastic shell was used additionally. The surgical treatment was supplemented with an intensive treatment with topical corticosteroids to decrease the inflammatory reaction.
RESULTS: The patients were followed for an average of 7-18 months. The interval between the accident and the transplantation ranged from 2-26 months. In 10 patients a reconstruction of the fornices was achieved. In all patients, however, some slight scars could be observed. Postoperative Schirmertest was markedly improved. These results encourage us to plan a penetrating keratoplasty in 7 cases. 3 patients showed a recurrence of the symblepharon 2 months after the transplantation.
CONCLUSION: The nasal mucosa graft material is best suited for repair of extensive symblepharon. The advantages of this tissue are the availability of large pieces of mucosa and the transplantation of intraepithelial goblet-cells. Long-term effects are the improvement and stabilisation of the tear film.

Entities:  

Mesh:

Year:  1994        PMID: 8196301     DOI: 10.1055/s-2008-1035513

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  1 in total

1.  A rabbit model for assessing symblepharon after alkali burn of the superior conjunctival sac.

Authors:  Yanwei Kang; Shaowei Li; Chang Liu; Mintian Liu; Shuai Shi; Man Xu; Jingliang He; Tao Zhang
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.